Amolyria × GEN Helvetia: a partnership in Geneva
Amolyria partners with GEN Helvetia in Geneva: Alexandra Levy brings neurophysiological regulation expertise and tests the emotional support platform.
We are proud to announce a partnership that takes Amolyria further: Alexandra Levy, founder of GEN Helvetia in Geneva, brings her expertise in neurophysiological regulation to the platform and tests it in real-life conditions.
Why this partnership
Supporting a person is never the work of a single discipline. A digital companion available at any hour becomes more accurate when it is shaped by several perspectives: clinical practice, regulation and technology.
Alexandra Levy's role: to bring her expertise alongside the fieldwork of Daria Egorova, co-founder, psychologist and visual art therapist, and to test the platform with the precision and measure that characterise her practice.
Who is GEN Helvetia
GEN offers non-medical regulation and performance support for executives, elite athletes and high-demand professions. Based at the Institut Médico-Chirurgical de Champel in Geneva, GEN relies on the Quertant method (Psycho-Sensory Culture), a non-verbal, progressive and measurable neurofunctional training.
What this means for you
- Complementary expertise — a regulation practitioner's perspective enriches how the platform supports, reassures and guides.
- Usage testing — Alexandra explores Amolyria's journeys, tone and pace, then shares her observations with the team.
- Continuous improvement — her feedback informs how the service evolves, through regular exchanges.
"My work is helping highly solicited people regain stable regulation. My expertise complements the fieldwork of Daria Egorova, psychologist: we are stronger together than each on our own. Testing Amolyria means checking that the platform supports people accurately and respectfully, without ever promising what it cannot deliver."
— Alexandra Levy, founder of GEN Helvetia
"No one supports others well in isolation. Daria Egorova's clinical work is the foundation of Amolyria. Alexandra Levy's expertise complements it with the rigour of a precision practice. Stronger together, and more thoughtful in our approach: Amolyria remains a complement, never a substitute."
— Christophe Robert, co-founder and CEO of Amolyria
Our commitments, unchanged
Tests are carried out on trial accounts: no real user data is shared with GEN Helvetia. Amolyria complements the medical, psychological and community support network — it does not replace it. This collaboration is expert feedback; it is neither a medical or scientific validation, nor a certification of the platform.